Peter Salzmann's Net Worth

$45.2 Million

Estimate Recalculated Nov 1, 2024 05:49AM EST

Who is Peter Salzmann?

Peter Salzmann has an estimated net worth of $45.2 Million. This is based on reported shares across multiple companies, which include Immunovant, Inc., and Corbus Pharmaceuticals Holdings, Inc..

SEC CIK

Peter Salzmann's CIK is 0001796309

Past Insider Trading and Trends

2021 was Peter Salzmann's most active year for acquiring shares with 7 total transactions. Peter Salzmann's most active month to acquire stocks was the month of April. 2023 was Peter Salzmann's most active year for disposing of shares, totalling 12 transactions. Peter Salzmann's most active month to dispose stocks was the month of July. 2019 saw Peter Salzmann paying a total of $0.00 for 1,479,043 shares, this is the most they've acquired in one year. In 2023 Peter Salzmann cashed out on 293,276 shares for a total of $6,564,261.77, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Immunovant, Inc. (IMVT) Snapshot price: $34

Chief Executive Officer

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-0.91%
-9.10K
$28.79
-$261,845.05
994.79K
Oct 16
Form 4
-0.44%
-4.46K
$29.56
-$131,837.60
1M
Oct 9
Form 4
-1.47%
-15.07K
$31.86
-$480,052.16
1.01M
Aug 21
Form 4
-0.84%
-8.69K
$29.69
-$257,887.50
1.02M
Jul 17
Form 4
-0.45%
-4.62K
$28.06
-$129,609.14
1.03M
Jul 9
Form 4
-1.54%
-16.16K
$29.65
-$479,232.95
1.04M
May 22
Form 4
-3.14%
-34.08K
$29.06
-$990,269.16
1.05M
Apr 17
Form 4
-0.44%
-4.81K
$31.18
-$149,882.26
1.09M
Apr 9
Form 4
+17.24%
160.53K
—
—
1.09M
Apr 2
Form 4
-1.42%
-13.45K
$36.15
-$486,362.10
931.23K
Feb 22
Form 4
-0.40%
-3.82K
$38.59
-$147,568.16
944.68K
Jan 5
Form 4
-1.68%
-16.22K
$32.78
-$531,581.07
948.51K
Nov 22
Form 4
-0.54%
-5.24K
$36.24
-$189,887.31
964.73K
Oct 5
Form 4
-5.53%
-56.77K
$22.02
-$1,250,337.86
969.97K
Aug 30
Form 4
-9.12%
-103.06K
$21.42
-$2,207,177.52
1.03M
Aug 14
Form 4
-8.23%
-101.34K
$21.73
-$2,202,096.47
1.13M
Aug 7
Form 4
-0.26%
-3.23K
$19.73
-$63,787.09
1.23M
Jul 12
Form 4
-0.27%
-3.40K
$15.27
-$51,841.65
1.23M
Apr 18
Form 4
+24.53%
243.83K
—
—
1.24M
Apr 12
Form 4
-0.40%
-4.02K
$16.80
-$67,552.80
993.93K
Jan 11
Form 4
-0.28%
-2.79K
$9.18
-$25,639.74
1M
Oct 13
Form 4
-0.16%
-1.60K
$4.67
-$7,495.35
1M
Sep 28
Form 4
-0.16%
-1.64K
$5.83
-$9,584.52
1M
Aug 30
Form 4
+81.64%
451.26K
—
—
1M
Aug 17
Form 4
-0.28%
-1.53K
$4.27
-$6,524.56
552.73K
Jul 27
Form 4
-0.25%
-1.38K
$4.02
-$5,531.52
554.26K
Jun 29
Form 4
-0.26%
-1.47K
$3.79
-$5,575.09
555.63K
May 24
Form 4
-0.29%
-1.62K
$4.72
-$7,655.84
557.11K
Apr 27
Form 4
-3.33%
-19.23K
$5.90
-$113,439.30
558.73K
Mar 24
Form 4
-17.80%
-125.16K
$7.25
-$907,395.50
577.96K
Jan 7
Form 4
—
0
—
—
0
Sep 11
Form 4
+430.65%
570.61K
—
—
703.11K
Aug 3
Form 4
∞
132.5K
—
—
132.5K
Mar 19
Form 4
—
0
—
—
0
May 15
Form 4
—
0
—
—
0
Dec 18
Form 3
—
0
—
—
0
No matching records found

Corbus Pharmaceuticals Holdings, Inc. (CRBP) Snapshot price: $50.04

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
∞
2.78K
—
—
2.78K
May 30
Form 4
—
0
—
—
0
May 16
Form 4
—
0
—
—
0
May 18
Form 4
—
0
—
—
0
May 18
Form 4
—
0
—
—
0
Jun 17
Form 4
—
0
—
—
0
May 20
Form 4
—
0
—
—
0
Mar 6
Form 3
—
0
—
—
0
No matching records found